Celldex Therapeutics announces reverse stock split
Celldex Therapeutics announced its Board of Directors has approved a one-for-fifteen reverse stock split of its common stock. Beginning on Feb. 11, 2019, Celldex’s common stock will trade on the Nasdaq Capital Market on a split-adjusted. February 08, 2019